Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126093891 | 12609389 | 1 | I | 20160718 | 20160801 | 20160801 | EXP | US-AUROBINDO-AUR-APL-2016-09750 | AUROBINDO | 82.00 | YR | M | Y | 0.00000 | 20160801 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126093891 | 12609389 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | U | U | 203294 | |||||||||
| 126093891 | 12609389 | 2 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Unknown | U | U | 0 | |||||||||
| 126093891 | 12609389 | 3 | SS | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 126093891 | 12609389 | 4 | SS | Vancomycin | VANCOMYCIN | 1 | Unknown | U | U | 0 | |||||||||
| 126093891 | 12609389 | 5 | SS | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 126093891 | 12609389 | 6 | SS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | Intravenous (not otherwise specified) | 1 GRAM EVERY 6 HOURS | U | U | 0 | ||||||||
| 126093891 | 12609389 | 7 | SS | LINEZOLID. | LINEZOLID | 1 | Intravenous (not otherwise specified) | 600 MG, EVERY 12 HOURS | U | U | 0 | 600 | MG | ||||||
| 126093891 | 12609389 | 8 | SS | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126093891 | 12609389 | 9 | SS | AMIKACIN | AMIKACIN | 1 | Unknown | U | U | 0 | |||||||||
| 126093891 | 12609389 | 10 | SS | AMPICILLIN W/SULBACTAM /00892601/ | AMPICILLIN SODIUMSULBACTAM SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 126093891 | 12609389 | 11 | SS | CEFOXITIN | CEFOXITIN SODIUM | 1 | Unknown | U | U | 0 | |||||||||
| 126093891 | 12609389 | 12 | SS | ERTAPENEM | ERTAPENEM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126093891 | 12609389 | 13 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126093891 | 12609389 | 1 | Product used for unknown indication |
| 126093891 | 12609389 | 2 | Product used for unknown indication |
| 126093891 | 12609389 | 3 | Product used for unknown indication |
| 126093891 | 12609389 | 4 | Product used for unknown indication |
| 126093891 | 12609389 | 5 | Product used for unknown indication |
| 126093891 | 12609389 | 6 | Product used for unknown indication |
| 126093891 | 12609389 | 7 | Product used for unknown indication |
| 126093891 | 12609389 | 8 | Product used for unknown indication |
| 126093891 | 12609389 | 9 | Product used for unknown indication |
| 126093891 | 12609389 | 10 | Product used for unknown indication |
| 126093891 | 12609389 | 11 | Product used for unknown indication |
| 126093891 | 12609389 | 12 | Product used for unknown indication |
| 126093891 | 12609389 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126093891 | 12609389 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126093891 | 12609389 | Drug resistance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |